Carbapenem-Resistant Klebsiella pneumoniae: Virulence Factors, Molecular Epidemiology and Latest Updates in Treatment Options

T Karampatakis, K Tsergouli, P Behzadi - Antibiotics, 2023 - mdpi.com
Klebsiella pneumoniae is a Gram-negative opportunistic pathogen responsible for a variety
of community and hospital infections. Infections caused by carbapenem-resistant K …

[HTML][HTML] Clinical data from studies involving novel antibiotics to treat multidrug-resistant Gram-negative bacterial infections

SS Kanj, M Bassetti, P Kiratisin, C Rodrigues… - International journal of …, 2022 - Elsevier
Abstract Multidrug-resistant (MDR) Gram-negative bacteria (GNB) pose a critical threat to
global healthcare, worsening outcomes and increasing mortality among infected patients …

Pharmaceutical approaches on antimicrobial resistance: prospects and challenges

F Nainu, AD Permana, NJN Djide, QK Anjani… - Antibiotics, 2021 - mdpi.com
The rapid increase in pathogenic microorganisms with antimicrobial resistant profiles has
become a significant public health problem globally. The management of this issue using …

Anti-Pseudomonas aeruginosa Vaccines and Therapies: An Assessment of Clinical Trials

MM Elmassry, JA Colmer-Hamood, J Kopel… - Microorganisms, 2023 - mdpi.com
Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen that causes high
morbidity and mortality in cystic fibrosis (CF) and immunocompromised patients, including …

Tackling the outer membrane: facilitating compound entry into Gram-negative bacterial pathogens

D Saxena, R Maitra, R Bormon, M Czekanska… - npj Antimicrobials and …, 2023 - nature.com
Emerging resistance to all available antibiotics highlights the need to develop new
antibiotics with novel mechanisms of action. Most of the currently used antibiotics target …

Exploiting the fitness cost of metallo-β-lactamase expression can overcome antibiotic resistance in bacterial pathogens

MM Tu, LA Carfrae, K Rachwalski, S French… - Nature …, 2025 - nature.com
Carbapenems are last-resort antibiotics for treating bacterial infections. The widespread
acquisition of metallo-β-lactamases, such as VIM-2, contributes to the emergence of …

Antimicrobial activity of aztreonam in combination with old and new β-lactamase inhibitors against MBL and ESBL co-producing Gram-negative clinical isolates …

G Morroni, R Bressan, S Fioriti, G D'Achille, M Mingoia… - Antibiotics, 2021 - mdpi.com
Metallo-β-lactamases (MBLs) are among the most challenging bacterial enzymes to
overcome. Aztreonam (ATM) is the only β-lactam not hydrolyzed by MBLs but is often …

A randomized non-inferiority study comparing imipenem/cilastatin/relebactam with standard-of-care Gram-negative coverage in cancer patients with febrile …

AM Chaftari, H Dagher, R Hachem… - Journal of …, 2024 - academic.oup.com
Background Antibiotic overuse leads to the emergence of antibiotic resistance that threatens
immunocompromised cancer patients. Infections caused by MDR Gram-negative pathogens …

The role of the respiratory microbiome in the pathogenesis of aspiration pneumonia: Implications for diagnosis and potential therapeutic choices

NG Vallianou, A Skourtis, D Kounatidis, E Margellou… - Antibiotics, 2023 - mdpi.com
Although the lungs were considered to be sterile until recently, the advent of molecular
biology techniques, such as polymerase chain reaction, 16 S rRNA sequencing and …

Agents targeting the bacterial cell wall as tools to combat Gram-positive pathogens

A Zhydzetski, Z Głowacka-Grzyb, M Bukowski… - …, 2024 - pmc.ncbi.nlm.nih.gov
The cell wall is an indispensable element of bacterial cells and a long-known target of many
antibiotics. Penicillin, the first discovered beta-lactam antibiotic inhibiting the synthesis of cell …